Clin Chem. 2012 Jan;58(1):45-53

Authors: Halim SA, Newby LK, Ohman EM

Abstract
BACKGROUND: Cardiovascular (CV) clinical trials are instrumental in understanding treatment effects and offer insights into the natural progression of CV disease. Biomarkers are a critical component of patient selection, end point definition, and safety monitoring, and clinical trials provide a platform for the discovery and validation of new biomarkers that may augment the understanding of disease mechanisms, risk stratification, and/or clinical decision-making.
CONTENT: We review the roles that biomarkers have played in CV clinical trials and roles that CV clinical trials have played and will continue to play in the discovery and validation of biomarkers and their implementation in clinical practice. Large biobanks containing multiple specimen types are increasingly being created from patients enrolled in clinical trials, and such biobanks, when coupled with advances in molecular techniques and bioinformatics, promise to accelerate our understanding of CV disease mechanisms and to help fuel the discovery and development of novel therapeutic targets and biomarkers of risk and treatment response.
SUMMARY: The past, present, and future of biomarkers and clinical trials have been and will remain intertwined. Biomarkers were once the workhorses of patient selection and end point definition in clinical trials; more recently, clinical trials have been the proving ground for individual biomarkers. Attention to biobanking and the application of modern informatics and molecular techniques to samples collected within clinical trials will usher in the era of stratified and personalized medicine.

PMID: 22205775 [PubMed - in process]

cheap viagra 100mg

Generally, the prognosis for ED is good. Some men will just need to make some lifestyle changes, such as losing weight and taking regular exercise. Other men may need to take medication such as sildenafil (known as Viagra). What precautions should be taken when using tadalafil? Abstract DRAMATIC ADVANCES IN THE MANAGEMENT of erectile dysfunction have occurred over the past decade. Oral therapy with vasoactive agents has emerged as first-line treatment and has transformed both the manner in which the public views erectile dysfunction and the way health care providers deliver care. Whereas an extensive investigation was previously common in the management of erectile dysfunction, recent treatment guidelines promote a more minimalist, goal-oriented approach. In this article, we review the physiology of erection, and the pathophysiology, diagnosis and clinical management of erectile dysfunction. We also present the existing evidence for the efficacy of 3 phosphodiesterase inhibitors, the most widely used class of agents for erectile dysfunction. Paolo Serafini1, Kristen Meckel1, Michael Kelso1, Kimberly Noonan1, Joseph Califano2, Wayne Koch2, Luigi Dolcetti3, Vincenzo Bronte3, and Ivan Borrello1 Gene therapy: This novel therapy would deliver genes that produce products or proteins that may not be functioning properly in the penile tissue of men with ED. Replacement of these proteins may result in improvement in erectile function. Experimental animal models have demonstrated improvement in erectile function with gene therapy. Human studies may also demonstrate success with this therapy. Gene therapy may take a long time for regulatory approval and public acceptance. Diabetes mellitus: Erectile dysfunction tends to develop 10-15 years earlier in diabetic men than among nondiabetic men. In a population study of men with type I diabetes for more than 10 years, erectile dysfunction was reported by 55% of men between the ages of 50 to 60 years. The increased risk of erectile dysfunction among men with diabetes mellitus may be due to the earlier onset and greater severity of atherosclerosis that narrows the arteries and thereby reduces the delivery of blood to the penis. When insufficient blood is delivered to the penis, it is not possible to achieve an erection. Thompson and his colleagues provided the first substantial evidence linking erectile dysfunction and subsequent risk for heart disease in a December 2005 report in the Journal of the American Medical Association. Yet the connection is not as well recognized among doctors and patients as cardiologists and urologists think it should be. If you experience side effects such as nausea, vomiting, rapid heartbeat, anxiety, insomnia, diarrhea, or skin rashes, stop taking the herbal product and notify your doctor. In other words, the complex chemical process behind your erection can be interrupted if the vascular, or blood vessel, system isn’t functioning correctly. Atherosclerosis, the build-up of plaque in your blood vessels, can also increase erectile dysfunction risk by reducing blood flow throughout the body. In addition, always follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part that you do not understand. Take these drugs exactly as directed. Do not take more or less or take it more often than prescribed by your doctor. Do not take these drugs more than once a day. As for the current study, Vorona said it makes sense that the two conditions might be linked "on a physiological basis," perhaps through dopamine. Because of the impact of HIV care on other aspects of health -- for example, cardiovascular well-being -- HIV-positive patients and their doctors are increasingly aware of trends across a wide variety of medical specialities. In many cases, these specialities -- such as virology and cardiovascular disease -- used to have little in common, Patton explained. Advertising Disclaimer Hypertension (high blood pressure): Patients with essential hypertension or arteriosclerosis have an increased risk of developing erectile dysfunction. Essential hypertension is the most common form of hypertension; it is called essential hypertension because it is not caused by another disease, (for example, by kidney disease). It is not clearly known how essential hypertension causes erectile dysfunction; however, patients with essential hypertension have been found to have low production of nitric oxide by the arteries of the body, including the arteries in the penis. Scientists now suspect that the decreased levels of nitric oxide in patients with essential hypertension may contribute to erectile dysfunction. For more information, please read the High Blood Pressure article. Furthermore, different styles of intoxication like drug abuse and smoking have been shown to be the outright cause of almost a fourth of all dysfunctions. cialis online